Arcturus Therapeutics Holdings Inc. ARCT
13.85
(0.27)
(1.91%)
as of 25 Sep
- Market cap
- $412.4M
- P/E
- 0.0×
Follow ARCT
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 49.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
2.05 | 3.01 | 5.28 | 2.14 | 78.81 | 92.34 | 6.31 | 2.90 | 0.00 | 0.00 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 18.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(10.35) | (1,613.35) | (1,400.83) | 2.76 | (22.92) | (132.82) | (17.40) | (7.91) | 4.93 | 2.54 |
P/B ratio |
0.78 | 1.90 | 3.16 | 1.63 | 4.27 | 2.22 | 5.09 | 3.34 | 0.73 | 19.93 |
Price to Tangible BV |
0.78 | 1.90 | 3.16 | 1.63 | 4.27 | 2.22 | 5.09 | 3.34 | 0.73 | 19.93 |
EV/Sales |
(0.53) | 1.25 | 3.35 | 0.68 | 53.94 | 45.40 | 3.61 | 1.20 | 0.00 | 0.00 |
EV/EBITDA |
0.60 | 0.00 | 0.00 | 10.26 | 0.00 | 0.00 | 0.00 | 0.00 | 2.37 | 0.00 |
EV/Operating CF |
0.59 | (3.19) | (30.85) | 4.40 | (4.94) | (10.10) | (11.63) | (0.91) | 52.05 | (8.12) |
EV/FCF |
0.59 | (3.15) | (26.59) | 5.79 | (4.81) | (9.71) | (10.32) | (0.85) | 35.10 | (6.54) |
Quick Ratio |
6.50 | 4.52 | 4.62 | 3.11 | 3.76 | 9.39 | 3.45 | 3.28 | 4.46 | 1.37 |
Current Ratio |
6.64 | 4.67 | 4.72 | 3.18 | 3.81 | 9.45 | 3.48 | 3.33 | 4.61 | 1.41 |
Net Debt/EBITDA |
3.15 | 3.17 | 4.61 | (21.97) | 1.52 | 6.34 | 2.24 | 1.26 | 4.83 | 11.63 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 20.18% | 16.07% | 3.17% | 19.26% | 22.42% | 0.00% | 0.97% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.34 | 0.28 | 0.04 | 0.61 | 0.73 | 0.00 | 0.08 |
Asset Turnover |
0.27 | 0.39 | 0.38 | 0.49 | 0.03 | 0.03 | 0.33 | 0.33 | 0.40 | 0.48 |
Operating CF/Net income |
1.13 | 0.74 | 0.61 | 3.42 | 0.66 | 0.59 | 0.25 | 0.95 | 0.04 | 1.82 |
Capex/Depreciation |
(0.08) | (0.18) | (0.98) | (5.06) | (2.85) | (1.98) | (1.20) | (2.54) | (0.54) | (2.34) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (28.92%) | (31.16%) | (10.83%) | 3.75% | (65.20%) | (34.17%) | (131.82%) | (91.85%) | (61.64%) | (4.43%) | |
| (21.39%) | (20.93%) | (6.76%) | 2.22% | (46.86%) | (25.83%) | (41.14%) | (45.28%) | (33.16%) | (3.68%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(31.06%) | (32.37%) | (9.38%) | 3.24% | (71.45%) | (17.11%) | (46.99%) | (69.77%) | (26.67%) | (31.85%) |
Average Days of Receivables |
24.76 | 9.52 | 70.16 | 4.90 | 99.44 | 81.31 | 38.26 | 103.83 | 13.48 | 65.06 |
Research and Development Expense of Revenue |
136.79% | 128.13% | 115.19% | 71.72% | 1,405.94% | 606.42% | 161.82% | 107.80% | 122.46% | 87.99% |
Selling, General and Administrative Expense of Revenue |
56.17% | 34.68% | 31.70% | 22.36% | 335.39% | 243.39% | 60.91% | 130.65% | 58.26% | 16.92% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
30.97% | 24.94% | 20.77% | 14.86% | 233.96% | 70.91% | 9.53% | 7.99% | 16.69% | 1.47% |
Graham Net Nets |
1.10 | 0.44 | 0.27 | 0.51 | 0.22 | 0.44 | 0.14 | 0.25 | 1.32 | 0.01 |
Graham Number |
0.00 | 0.00 | 0.00 | 8.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(38.83%) | (17.74%) | (3.38%) | 2.04% | (20.91%) | (7.81%) | (19.04%) | (47.80%) | (44.40%) | (40.29%) |
Free Cash Flow Yield |
(44.38%) | (13.18%) | (2.38%) | 5.49% | (14.21%) | (5.06%) | (5.54%) | (48.75%) | (2.77%) | (11.29%) |
Revenue per Share |
3.00 | 5.64 | 6.26 | 7.79 | 0.47 | 0.47 | 1.72 | 1.56 | 4.21 | 10.03 |
Operating CF per Share |
(2.71) | (2.21) | (0.68) | 1.21 | (5.13) | (2.11) | (0.53) | (2.06) | (0.15) | (1.41) |
Capex per Share |
(0.01) | (0.02) | (0.11) | (0.29) | (0.13) | (0.09) | (0.07) | (0.15) | (0.07) | (0.34) |
Free Cash Flow per Share |
(2.72) | (2.24) | (0.79) | 0.92 | (5.26) | (2.20) | (0.60) | (2.21) | (0.22) | (1.75) |
Cash per Share |
8.43 | 10.82 | 13.03 | 14.82 | 14.08 | 22.80 | 5.91 | 3.65 | 15.79 | 4.11 |
Shareholders Equity per Share |
7.81 | 8.93 | 10.46 | 10.22 | 8.67 | 19.53 | 2.14 | 1.35 | 10.95 | 0.78 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
7.81 | 8.93 | 10.46 | 10.22 | 8.67 | 19.53 | 2.14 | 1.35 | 10.95 | 0.78 |
Free Cash Flow |
(74.50) | (60.39) | (21.00) | 24.27 | (138.45) | (44.60) | (7.26) | (22.24) | (0.68) | (3.55) |
Working Capital |
205.07 | 240.49 | 304.60 | 276.35 | 279.42 | 418.27 | 52.97 | 29.25 | 39.83 | 3.60 |
Capital Expenditures |
(0.23) | (0.65) | (2.90) | (7.73) | (3.41) | (1.74) | (0.82) | (1.48) | (0.22) | (0.69) |
Net Current Asset Value |
184.28 | 202.89 | 235.70 | 223.26 | 214.36 | 387.89 | 17.94 | 11.27 | 32.64 | 0.17 |
EV/EBIT |
0.57 | 0.00 | 0.00 | 11.55 | 0.00 | 0.00 | 0.00 | 0.00 | 2.28 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.02 | 0.04 | 0.28 | 0.18 | 0.04 | 0.09 | 0.02 | 0.03 |
Net Profit Margin |
(80.19%) | (53.14%) | (17.82%) | 4.54% | (1,647.98%) | (756.35%) | (125.02%) | (138.29%) | (83.87%) | (7.71%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 36.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.45 | 0.37 | 0.24 | 0.12 | 0.21 | 0.26 | 0.29 | 0.29 | 0.39 | 0.22 |
Cash ROIC |
(18.21%) | (13.00%) | (4.88%) | 2.60% | (21.26%) | (5.29%) | (7.78%) | (37.73%) | (1.83%) | (41.73%) |
Accounts Receivable Turnover |
17.20 | 8.45 | 9.58 | 67.20 | 4.50 | 4.43 | 6.24 | 6.35 | 6.32 | 10.04 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | — | — | — | — | — | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | — | — | — | — | — | 0.00 | 0.00 |
Average Receivables |
4.77 | 18.02 | 17.41 | 3.07 | 2.75 | 2.15 | 3.33 | 2.48 | 2.06 | 2.03 |
Average Payables |
5.71 | 6.24 | 6.36 | 8.75 | 10.42 | 8.28 | 4.10 | 2.09 | 2.57 | 1.71 |
Average Assets |
307.61 | 386.74 | 439.89 | 421.60 | 434.64 | 279.30 | 63.17 | 48.11 | 32.88 | 42.71 |
Average Common Equity |
227.48 | 259.75 | 274.41 | 249.26 | 312.38 | 211.17 | 19.72 | 23.72 | 17.69 | 35.45 |
Columns are period end dates